Relugolix Catalog No.:M18801-C which represents a new structural

which represents a new structural class of non-nucleoside antiviral drugs

3 times/week

CN1CC(=CCC1)C(=O)OC

8a-octahydroazulen-1-ol

respectively

Relugolix Catalog No.:M18801-C which represents a new structuralRelugolix (TAK 385) is a potent, orally active, nonpeptidic gonadotropin releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0. 33 nM) and monkey receptor (IC50=0. 32 nM) compared with TAK 013 (HY 100209). Relugolix is used for the study of sex hormone dependent diseases, such as including endometriosis, uterine fibroids and prostate cancer et al. Product information